Our Centre is based on the Altnagelvin Hospital site in Derry/Londonderry in the C-TRIC building, which offers clinical research organisation services that were jointly established by Ulster University, the hospital trust and the city council.
Since its inception in 2013, the centre has secured more than £24m in competitive grant funding and published more than 380 peer-reviewed articles in prestigious top quartile journals (correct as of May 2022). At the forefront of innovation in personalised and precision medicine, the centre has secured 14 patent applications in novel therapeutic and diagnostic advances. The centre contributed to Ulster University’s ranking in the top five universities in the UK in research power in the Allied Health Professions, with 95% of our impact in REF2021 judged to be world-leading or internationally excellent.
We have the largest single critical mass of researchers solely focused on personalised medicine in Ireland. We have some 23 Core staff, 49 Research associates/assistants and PhD researchers, and some 36 NHS Clinicians affiliated with our Research centre linking General Practitioners (GPs) and NHS Health Trusts (predominantly from the Western Health & Social Care Trust at Altnagelvin Hospital).
In addition to our own core team of bioinformaticians/data scientists, biochemists, molecular biologists and clinicians, we also work closely with the Intelligent Systems Research Centre within the Faculty of Computing & Engineering at Ulster University, particularly in relation to advanced data analytics.
What is Personalised Medicine?
Personalised medicine (also known as precision or stratified medicine) is an approach which subdivides patients into groups based on their risk of developing specific diseases or their response to particular therapies. Personalised medicine is recognised as a key global priority for healthcare providers, pharmaceutical and diagnostic industries and patients. The ultimate aim of a personalised approach to prescribing medicine is to enable healthcare professionals to provide the 'right treatment, for the right person, at the right time.'
Personalised Medicine relies on using biological markers along with imaging and clinical data to separate patients into specific groups for diagnosing and treating disease in more effective ways or at earlier time points than currently possible. In order to realise the potential benefits of personalised medicine, advances in technologies and systems are required to reliably predict disease, select the best treatment and reduce side effects for each individual patient.